Work

Early Bacterial Bloodstream Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Microbiology and Outcomes in a Single Turkish Center

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background/Objectives: Bloodstream infections (BSIs) are a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), and reported incidence depends on how skin commensals are adjudicated. We describe the epidemiology, microbiology, risk factors, and survival impact of early (day 0–30) bacterial BSI at a Turkish transplant center. Methods: We retrospectively studied 155 consecutive allo-HSCT episodes in 153 adults (April 2017–January 2026). Single-isolate coagulase-negative staphylococci (CoNS) were classified as contaminants. Cumulative incidence was estimated with the Aalen–Johansen estimator and survival with day-30 landmark and time-dependent Cox models. Results: Bacterial BSI occurred in 20 episodes (30-day cumulative incidence 12.9%, 95% CI 8.2–18.7) at a median of 14 days; counting single-isolate CoNS would have raised incidence to 40.0%. Of 22 isolates, 15 (68.2%) were Gram-negative and 12 (54.5%) were Escherichia coli. An extended-spectrum β-lactamase phenotype was present in nine episodes. Among 14 Gram-negative episodes with susceptibility data, 71.4% were fluoroquinolone-resistant and 92.9% meropenem-susceptible; empirical therapy was active in 16 of 20 episodes (80.0%). No baseline covariate predicted BSI, and early BSI was not associated with overall survival (adjusted HR 0.75, 95% CI 0.34–1.64). Conclusions: Early bacterial BSI was predominantly Gram-negative and E. coli-driven, with frequent fluoroquinolone resistance but preserved carbapenem susceptibility. Contaminant adjudication substantially altered incidence and should be stated explicitly.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,258
OpenAlex ID: W7225915161
FWCI:
Cites: 42
Cited by:
Related to: 10